Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 16161, 7 pages
http://dx.doi.org/10.1155/MI/2006/16161
Research Communication

JAK Inhibitors AG-490 and WHI-P154 Decrease IFN-γ-Induced iNOS Expression and NO Production in Macrophages

The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, 33014 Tampere, Finland

Received 10 January 2006; Accepted 28 January 2006

Copyright © 2006 Outi Sareila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D A Geller and T R Billiar, “Molecular biology of nitric oxide synthases,” Cancer and Metastasis Reviews, vol. 17, no. 1, pp. 7–23, 1998. View at Publisher · View at Google Scholar
  2. H Kleinert, A Pautz, K Linker, and P M Schwarz, “Regulation of the expression of inducible nitric oxide synthase,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 255–266, 2004. View at Publisher · View at Google Scholar
  3. J MacMicking, Q W Xie, and C Nathan, “Nitric oxide and macrophage function,” Annual Review of Immunology, vol. 15, pp. 323–350, 1997. View at Publisher · View at Google Scholar
  4. R Korhonen, A Lahti, H Kankaanranta, and E Moilanen, “Nitric oxide production and signaling in inflammation,” Current Drug Targets. Inflammation and Allergy, vol. 4, no. 4, pp. 471–479, 2005. View at Publisher · View at Google Scholar
  5. E Moilanen, B J Whittle, and S Moncada, “Nitric oxide as a factor of inflammation,” in Inflammation: Basic Principles and Clinical Correlates, J I Gallin and R Snyderman, Eds., pp. 787–801, Lippincott Williams & Wilkins, Philadelphia, Pa, 1999. View at Google Scholar
  6. S P Sanders, “Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?” American Journal of Respiratory Cell and Molecular Biology, vol. 21, no. 2, pp. 147–149, 1999. View at Google Scholar
  7. R J van't Hof and S H Ralston, “Nitric oxide and bone,” Immunology, vol. 103, no. 3, pp. 255–261, 2001. View at Google Scholar
  8. P Vallance and J Leiper, “Blocking NO synthesis: how, where and why?” Nature Reviews. Drug Discovery, vol. 1, no. 12, pp. 939–950, 2002. View at Publisher · View at Google Scholar
  9. L C Platanias, “Mechanisms of type-I- and type-II-interferon-mediated signalling,” Nature Reviews. Immunology, vol. 5, no. 5, pp. 375–386, 2005. View at Publisher · View at Google Scholar
  10. A Lahti, U Jalonen, H Kankaanranta, and E Moilanen, “c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages,” Molecular Pharmacology, vol. 64, no. 2, pp. 308–315, 2003. View at Publisher · View at Google Scholar
  11. L C Green, D A Wagner, J Glogowski, P L Skipper, J S Wishnok, and S R Tannenbaum, “Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982. View at Publisher · View at Google Scholar
  12. L B Ivashkiv and X Hu, “Signaling by STATs,” Arthritis Research & Therapy, vol. 6, no. 4, pp. 159–168, 2004. View at Google Scholar
  13. W J Leonard and J J O'Shea, “Jaks and STATs: biological implications,” Annual Review of Immunology, vol. 16, pp. 293–322, 1998. View at Publisher · View at Google Scholar
  14. T Kisseleva, S Bhattacharya, J Braunstein, and C W Schindler, “Signaling through the JAK/STAT pathway, recent advances and future challenges,” Gene, vol. 285, no. 1-2, pp. 1–24, 2002. View at Publisher · View at Google Scholar
  15. L Gatto, C Berlato, V Poli et al., “Analysis of SOCS-3 promoter responses to interferon gamma,” The Journal of Biological Chemistry, vol. 279, no. 14, pp. 13746–13754, 2004. View at Publisher · View at Google Scholar
  16. J Blanchette, M Jaramillo, and M Olivier, “Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation,” Immunology, vol. 108, no. 4, pp. 513–522, 2003. View at Publisher · View at Google Scholar
  17. Q W Xie, Y Kashiwabara, and C Nathan, “Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase,” The Journal of Biological Chemistry, vol. 269, no. 7, pp. 4705–4708, 1994. View at Google Scholar
  18. J Gao, D C Morrison, T J Parmely, S W Russell, and W J Murphy, “An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide,” The Journal of Biological Chemistry, vol. 272, no. 2, pp. 1226–1230, 1997. View at Publisher · View at Google Scholar
  19. M A Meraz, J M White, K C Sheehan et al., “Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway,” Cell, vol. 84, no. 3, pp. 431–442, 1996. View at Publisher · View at Google Scholar
  20. L Martinez-Lostao, J Briones, I Forne et al., “Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia,” Leukemia & Lymphoma, vol. 46, no. 3, pp. 435–442, 2005. View at Google Scholar
  21. E A Sudbeck, X P Liu, R K Narla et al., “Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents,” Clinical Cancer Research, vol. 5, no. 6, pp. 1569–1582, 1999. View at Google Scholar
  22. H Y Song, E S Jeon, J S Jung, and J H Kim, “Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells,” The International Journal of Biochemistry & Cell Biology, vol. 37, no. 11, pp. 2357–2365, 2005. View at Google Scholar
  23. H E Tibbles, A Vassilev, H Wendorf et al., “Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation,” The Journal of Biological Chemistry, vol. 276, no. 21, pp. 17815–17822, 2001. View at Publisher · View at Google Scholar
  24. R Korhonen, A Lahti, M Hamalainen, H Kankaanranta, and E Moilanen, “Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages,” Molecular Pharmacology, vol. 62, no. 3, pp. 698–704, 2002. View at Publisher · View at Google Scholar